Cash Flow Statement
Growth Metrics

Sintx Technologies (SINT) Net Cash Flow Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Sintx Technologies 8.71 Mn 6.82 Mn 144,000.00 -177.85%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -177.85%
Dec 31, 2025 -73.52%
Sep 30, 2025 650.97%
Jun 30, 2025 -81.00%
Mar 31, 2025 19.86%
Dec 31, 2024 57.57%
Sep 30, 2024 108.23%
Jun 30, 2024 63.14%
Mar 31, 2024 -61.87%
Dec 31, 2023 -292.87%
Sep 30, 2023 -4.48%
Jun 30, 2023 -25.39%
Mar 31, 2023 286.28%
Dec 31, 2022 151.54%
Sep 30, 2022 40.61%
Jun 30, 2022 -107.40%
Mar 31, 2022 -81.38%
Dec 31, 2021 -69.69%
Sep 30, 2021 -156.37%
Jun 30, 2021 -112.70%
Mar 31, 2021 -129.21%
Dec 31, 2020 -49.17%
Sep 30, 2020 3,455.26%
Jun 30, 2020 1,434.37%
Mar 31, 2020 525.45%
Dec 31, 2019 22.46%
Sep 30, 2019 86.30%
Jun 30, 2019 -108.51%
Mar 31, 2019 -383.39%
Dec 31, 2018 61.45%
Sep 30, 2018 -24.49%
Jun 30, 2018 350.17%
Mar 31, 2018 -1,179.31%
Dec 31, 2017 -3.06%
Sep 30, 2017 -128.58%
Jun 30, 2017 -24.96%
Mar 31, 2017 100.82%
Dec 31, 2016 -1,804.15%
Sep 30, 2016 584.72%
Jun 30, 2016 -12.06%
Mar 31, 2016 -5.26%
Dec 31, 2015 -97.25%
Sep 30, 2015 5.38%
Jun 30, 2015 -45.75%
Mar 31, 2015 -130.65%
Dec 31, 2014 249.29%
Sep 30, 2014 -118.52%
Jun 30, 2014 -68.51%
Mar 31, 2014 1,954.39%